ghk cu peptide shot GHK-Cu 50mg GHK-Cu | Peptide Therapy Pricing

Peptide Therapy Adults Over 60: Who Is and Is Not a Candidate Strong Candidates Adults 60+ with documented low IGF-1 on serum testing Individuals with sarcopenia confirmed by DEXA or functional testing Active seniors experiencing delayed recovery, poor sleep, and reduced energy not explained by other pathology Adults managing visceral obesity with inadequate response to diet and exercise Individuals already on andropause or menopause hormone therapy who want adjunctive metabolic support Poor Candidates or Contraindicated Any history of active cancer (especially hormone-sensitive: prostate, breast, colon) Uncontrolled diabetes (HbA1c above 8.5%) Severe cardiac or renal impairment Active intracranial pathology (GH secretagogues stimulate pituitary

milder deficiencies might respond well to oral pills

works well so far My weight loss journey started in November of 2025, but came to a hault due to the pricing under my pcp

The bottom line: peptides are a fascinating and rapidly evolving area of medicine with real potential

This compound is handled strictly in pre-clinical settings with no applications in human or veterinary medicine

Some start weekly for a short period, then move to every two to four weeks